“…Diagnostics spanning a wide range of biotechnologies, including genomics, proteomics, metabolomics, and nanotechnology, are emerging as companion tests to innovative medicines (Conde and Artzi, 2015;Higdon et al, 2015). The 19 th WHO Model List of Essential Medicines brings to the fore innovative medicines for hepatitis C, breast cancer, leukemia, and multi-drug resistant tuberculosis (World Health Organization, 2015).…”